HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xing-Mei Zhang Selected Research

Neoplasms (Cancer)

1/2022MTH1 as a target to alleviate T cell driven diseases by selective suppression of activated T cells.
11/2018Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity.
9/2015Proteomics Reveals a Role for Attachment in Monocyte Differentiation into Efficient Proinflammatory Macrophages.
10/2010γ-secretase inhibitor-I enhances radiosensitivity of glioblastoma cell lines by depleting CD133+ tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xing-Mei Zhang Research Topics

Disease

5Neuroinflammatory Diseases
01/2022 - 01/2012
4Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022 - 05/2014
4Neoplasms (Cancer)
01/2022 - 10/2010
4Inflammation (Inflammations)
01/2018 - 07/2011
4Experimental Autoimmune Neuritis
08/2011 - 02/2007
3Multiple Sclerosis
01/2022 - 05/2014
3Alzheimer Disease (Alzheimer's Disease)
12/2019 - 12/2005
3Demyelinating Diseases (Demyelinating Disease)
11/2016 - 02/2010
3Obesity
07/2015 - 01/2014
3Seizures (Absence Seizure)
01/2012 - 05/2008
2Autoimmune Diseases (Autoimmune Disease)
01/2022 - 11/2012
2Glioblastoma (Glioblastoma Multiforme)
11/2018 - 10/2010
2Glioma (Gliomas)
11/2018 - 10/2010
2Wounds and Injuries (Trauma)
01/2014 - 05/2013
2Disease Progression
08/2011 - 06/2011
2Body Weight (Weight, Body)
04/2010 - 05/2008
2Gliosis
05/2008 - 05/2007
1Myositis (Idiopathic Inflammatory Myopathies)
01/2020
1Amyloid Plaque
05/2019
1Breast Neoplasms (Breast Cancer)
12/2017
1Ischemia
10/2017
1Reperfusion Injury
10/2017
1Pathologic Processes
10/2017
1Pain (Aches)
08/2017
1Hypertension (High Blood Pressure)
01/2016
1Nervous System Diseases (Neurological Disorders)
01/2016
1Chronic Renal Insufficiency
01/2016
1Cardiovascular Diseases (Cardiovascular Disease)
01/2016
1Hyperinsulinism (Hyperinsulinemia)
01/2016
1Insulin Resistance
07/2015
1Peripheral Nerve Injuries
12/2014
1Neuralgia (Stump Neuralgia)
12/2014
1Central Nervous System Diseases (CNS Diseases)
02/2014
1Cicatrix (Scar)
01/2014
1Hypertrophic Cicatrix (Hypertrophic Scar)
01/2014
1Burns
01/2014

Drug/Important Bio-Agent (IBA)

4CytokinesIBA
05/2014 - 02/2007
3Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2017
3Apolipoproteins E (ApoE)IBA
01/2012 - 07/2011
3Interleukin-18 (Interleukin 18)IBA
04/2010 - 02/2007
2Therapeutic UsesIBA
01/2022 - 05/2014
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2016 - 06/2011
2Adenosine (Adenocard)FDA LinkGeneric
01/2016 - 07/2015
2Glucose (Dextrose)FDA LinkGeneric
01/2016 - 07/2015
2C-Type Lectins (C-Type Lectin)IBA
12/2014 - 05/2013
2Sirtuin 1IBA
10/2014 - 01/2014
2ApolipoproteinsIBA
01/2012 - 07/2011
2Apolipoprotein E2IBA
01/2012 - 08/2011
2Interleukin-6 (Interleukin 6)IBA
01/2012 - 07/2011
2Protein Isoforms (Isoforms)IBA
01/2012 - 07/2011
2AntigensIBA
07/2011 - 02/2010
2Myelin P0 Protein (Myelin Protein Zero)IBA
02/2010 - 02/2007
2Type I Tumor Necrosis Factor ReceptorsIBA
02/2010 - 05/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2010 - 05/2008
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1NucleotidesIBA
01/2022
19 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
01/2022
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2022
1Topotecan (Hycamtin)FDA LinkGeneric
01/2022
1CamptothecinIBA
01/2022
1karonudibIBA
01/2022
1Neuroprotective AgentsIBA
11/2020
1Myelin-Oligodendrocyte GlycoproteinIBA
09/2020
1TamoxifenFDA LinkGeneric
09/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1Amyloid (Amyloid Fibrils)IBA
12/2019
1Nucleotide AptamersIBA
12/2019
1ResveratrolIBA
05/2019
1Platelet-Derived Growth FactorIBA
11/2018
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
11/2018
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
11/2018
1Trastuzumab (Herceptin)FDA Link
12/2017
1Epidermal Growth Factor (EGF)IBA
12/2017
1Molecular Probes (Molecular Probe)IBA
12/2017
1Fluorescein (Funduscein)FDA LinkGeneric
12/2017
1Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2017
1NitratesIBA
10/2017
1Rocuronium (Zemuron)FDA LinkGeneric
08/2017
1Propofol (Diprivan)FDA LinkGeneric
08/2017
1Transforming Growth Factor beta (TGF-beta)IBA
11/2016
1Interleukin-12 (IL 12)IBA
11/2016
1Transforming Growth Factor-beta Type II ReceptorIBA
11/2016
1Apolipoprotein E4IBA
06/2016
1SaltsIBA
01/2016
1Adenosine A3 ReceptorIBA
01/2016
1SRT1720IBA
10/2014
1Complement System Proteins (Complement)IBA
02/2014
1Liposomes (Liposome)IBA
01/2014
1Hematoxylin (Haematoxylon)IBA
01/2014
1Eosine Yellowish-(YS) (Eosin)IBA
01/2014
1Clodronic Acid (Clodronate)IBA
01/2014
1CollagenIBA
01/2014
1Biological ProductsIBA
01/2012

Therapy/Procedure

5Therapeutics
01/2019 - 01/2014
1Injections
09/2020
1Transplantation
12/2017
1Cranial Irradiation
12/2016
1Ligation
12/2014
1Intraperitoneal Injections
01/2014
1Immunotherapy
11/2012